Rosemary A. Crane, CEO and President at MELA SCIENCES, INC. /NY (MELA), bought 67,570 shares at $0.74 ($50K) on 2014-02-05, disclosed to the SEC on 2014-02-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.